Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Cefaclor measurement |
Component |
True |
Cefaclor (substance) |
Inferred relationship |
Some |
1 |
Cefaclor poisoning |
Causative agent (attribute) |
True |
Cefaclor (substance) |
Inferred relationship |
Some |
1 |
Accidental cefaclor poisoning |
Causative agent (attribute) |
False |
Cefaclor (substance) |
Inferred relationship |
Some |
|
Intentional cefaclor poisoning |
Causative agent (attribute) |
False |
Cefaclor (substance) |
Inferred relationship |
Some |
|
intoxication par le céfaclor d'intention indéterminée |
Causative agent (attribute) |
False |
Cefaclor (substance) |
Inferred relationship |
Some |
1 |
Cefaclor adverse reaction |
Causative agent (attribute) |
True |
Cefaclor (substance) |
Inferred relationship |
Some |
1 |
Allergy to cefaclor (finding) |
Causative agent (attribute) |
False |
Cefaclor (substance) |
Inferred relationship |
Some |
|
Cefaclor overdose |
Causative agent (attribute) |
True |
Cefaclor (substance) |
Inferred relationship |
Some |
1 |
Accidental cefaclor overdose |
Causative agent (attribute) |
True |
Cefaclor (substance) |
Inferred relationship |
Some |
1 |
Intentional cefaclor overdose |
Causative agent (attribute) |
True |
Cefaclor (substance) |
Inferred relationship |
Some |
1 |
surdose de céfaclor d'intention indéterminée |
Causative agent (attribute) |
False |
Cefaclor (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely cefaclor 250 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefaclor (substance) |
Inferred relationship |
Some |
|
Cefaclor 500 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefaclor (substance) |
Inferred relationship |
Some |
|
Cefaclor 125mg/5mL s/f suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefaclor (substance) |
Inferred relationship |
Some |
|
Cefaclor 250mg/5mL s/f suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefaclor (substance) |
Inferred relationship |
Some |
|
Cefaclor 375mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefaclor (substance) |
Inferred relationship |
Some |
|
Cefaclor monohydrate 250mg/5mL powder for oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefaclor (substance) |
Inferred relationship |
Some |
|
Cefaclor 500mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefaclor (substance) |
Inferred relationship |
Some |
|
Cefaclor monohydrate 125mg/5 mL powder for oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefaclor (substance) |
Inferred relationship |
Some |
|
Cefaclor monohydrate 187mg/5 mL powder for oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefaclor (substance) |
Inferred relationship |
Some |
|
Cefaclor monohydrate 375mg/5 mL powder for oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefaclor (substance) |
Inferred relationship |
Some |
|
Product containing cefaclor (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cefaclor (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely cefaclor (as cefaclor monohydrate) 50 milligram/1 milliliter conventional release oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefaclor (substance) |
Inferred relationship |
Some |
|
Product containing precisely cefaclor 125 milligram/1 each conventional release chewable tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefaclor (substance) |
Inferred relationship |
Some |
|
Product containing precisely cefaclor 187 milligram/1 each conventional release chewable tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefaclor (substance) |
Inferred relationship |
Some |
|
Cefaclor 250mg chewable tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefaclor (substance) |
Inferred relationship |
Some |
|
Product containing precisely cefaclor 375 milligram/1 each conventional release chewable tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefaclor (substance) |
Inferred relationship |
Some |
|
Product containing precisely cefaclor (as cefaclor monohydrate) 25 milligram/1 milliliter conventional release oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefaclor (substance) |
Inferred relationship |
Some |
|
Accidental cefaclor poisoning |
Causative agent (attribute) |
True |
Cefaclor (substance) |
Inferred relationship |
Some |
1 |
Intentional cefaclor poisoning |
Causative agent (attribute) |
True |
Cefaclor (substance) |
Inferred relationship |
Some |
1 |
Allergy to cefaclor (finding) |
Causative agent (attribute) |
True |
Cefaclor (substance) |
Inferred relationship |
Some |
1 |
Cefaclor monohydrate (substance) |
Is a |
False |
Cefaclor (substance) |
Inferred relationship |
Some |
|
Product containing precisely cefaclor 250 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefaclor (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely cefaclor 250 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cefaclor (substance) |
Inferred relationship |
Some |
1 |
Cefaclor 500 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefaclor (substance) |
Inferred relationship |
Some |
1 |
Cefaclor 500 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cefaclor (substance) |
Inferred relationship |
Some |
1 |
Cefaclor monohydrate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Cefaclor (substance) |
Inferred relationship |
Some |
|
Cefaclor 500mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefaclor (substance) |
Inferred relationship |
Some |
|
Product containing precisely cefaclor (as cefaclor monohydrate) 375 milligram/1 each prolonged-release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Cefaclor (substance) |
Inferred relationship |
Some |
1 |
Product containing cefaclor in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cefaclor (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely cefaclor 250 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cefaclor (substance) |
Inferred relationship |
Some |
1 |
Cefaclor 500 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cefaclor (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely cefaclor (as cefaclor monohydrate) 25 milligram/1 milliliter conventional release oral suspension |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Cefaclor (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely cefaclor (as cefaclor monohydrate) 50 milligram/1 milliliter conventional release oral suspension |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Cefaclor (substance) |
Inferred relationship |
Some |
1 |
Product containing only cefaclor (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cefaclor (substance) |
Inferred relationship |
Some |
1 |
Product containing only cefaclor in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cefaclor (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely cefaclor (as cefaclor monohydrate) 250 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Cefaclor (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely cefaclor (as cefaclor monohydrate) 500 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Cefaclor (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely cefaclor 375 milligram/1 each conventional release chewable tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cefaclor (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely cefaclor 375 milligram/1 each conventional release chewable tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cefaclor (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely cefaclor 125 milligram/1 each conventional release chewable tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cefaclor (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely cefaclor 125 milligram/1 each conventional release chewable tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cefaclor (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely cefaclor 187 milligram/1 each conventional release chewable tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cefaclor (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely cefaclor 187 milligram/1 each conventional release chewable tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cefaclor (substance) |
Inferred relationship |
Some |
1 |
Cefaclor anhydrous |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Cefaclor (substance) |
Inferred relationship |
Some |
|
Product containing precisely cefaclor anhydrous (as cefaclor) 250 milligram/1 each conventional release chewable tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Cefaclor (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely cefaclor anhydrous (as cefaclor) 37.4 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cefaclor (substance) |
Inferred relationship |
Some |
1 |
Cefaclor anhydrous (as cefaclor) 75 mg/mL oral suspension |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cefaclor (substance) |
Inferred relationship |
Some |
1 |
Cefaclor 25 mg/mL oral suspension |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cefaclor (substance) |
Inferred relationship |
Some |
1 |
Cefaclor 25 mg/mL oral suspension |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cefaclor (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely cefaclor 375 milligram/1 each prolonged-release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cefaclor (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely cefaclor 375 milligram/1 each prolonged-release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cefaclor (substance) |
Inferred relationship |
Some |
1 |
Cefaclor 50 mg/mL oral suspension |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cefaclor (substance) |
Inferred relationship |
Some |
1 |
Cefaclor 50 mg/mL oral suspension |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cefaclor (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely cefaclor 250 milligram/1 each conventional release chewable tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cefaclor (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely cefaclor 250 milligram/1 each conventional release chewable tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cefaclor (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely cefaclor anhydrous (as cefaclor) 25 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cefaclor (substance) |
Inferred relationship |
Some |
1 |
Cefaclor 500 mg prolonged-release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cefaclor (substance) |
Inferred relationship |
Some |
1 |
Cefaclor 500 mg prolonged-release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cefaclor (substance) |
Inferred relationship |
Some |
1 |